Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
Org chart
Michael McElhaugh
Collapse
David C. Hastings
Chief Financial Officer
Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Michael J. Sofia Phd
Chief Scientific Officer
Karen Sims
Chief Medical Officer
Catherine Coffey Ross
Vice President Commercial Development
Michael Child
Vice President Clinical Operations
Shannon Briscoe
Vice President Human Resources
Ganapati Reddy Pamulapati
Senior Vice President, Pharmaceutical Development And Manufacturing
Similar companies
Kura Oncology
17 followers
SpringWorks Therapeutics
4 followers
Stemline Therapeutics
3 followers
Quantum-Si
2 followers
Sonoma Biotherapeutics
1 follower
Thermo Fisher Scientific
149 followers
Gilead Sciences
123 followers
Regeneron
89 followers
Neuralink
55 followers
GRAIL
27 followers
Guardant Health
13 followers
Discover companies